Highlights AB Science

Equities

AB

FR0010557264

Market Closed - Euronext Paris Other stock markets 11:35:14 2024-05-29 am EDT			5-day change	1st Jan Change
1.95 ^EUR	-1.12%		-7.80%	-45.15%

May. 30	Transcript : AB Science S.A. - Special Call
May. 29	AB Science: towards a negative opinion from the CHMP, listing suspended	CF

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

AB Science S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	May. 15	CI
AB Science: upbeat after legal success	May. 03	CF
French Appeals Court Acquits AB Science CEO of Insider Trading Charges	May. 03	MT
AB Science's Reconsideration Request for ALS Treatment Granted Eligibility in Canada	Apr. 04	MT
AB Science Announces Eligibility granted by Health Canada for Reconsideration Request for Masitinib in ALS	Apr. 03	CI
AB Science: encouraging results for masitinib	Mar. 13	CF
AB Science: share price falls, negative opinion in Canada	Feb. 27	CF
AB Science: share price falls, CHMP verdict postponed	Jan. 29	CF
AB Science: medical use patent for masitinib	Jan. 15	CF
AB Science Receives Notice of Allowance for European Patent Covering masitinib Until 2036 in the Treatment of mastocytosis	Jan. 15	CI
AB Science S.A. Reports Earnings Results for the Half Year Ended June 30, 2023	23-09-29	CI
Global markets live: Kingfisher, Tesla, Ulta Beauty, Amazon, Target...	23-09-19
Companies in Alzheimer's race after US nod for Eisai/Biogen drug	23-07-07	RE
AB Science Wins European Patent for Prostate Cancer Drug	23-06-27	MT
AB Science S.A. Receives Notice of Allowance for European Patent Covering Masitinib in the Treatment of Metastatic Castrate Refractory Prostate Cancer	23-06-26	CI
France's AB Science Secures Canadian Patent for Rare Neurological Disease Drug	23-06-02	MT
AB Science's Revised Application for Rare Neurological Disorder Drug Accepted for Review in Canada	23-05-10	MT
AB Science S.A. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-28	CI
AB Science S.A. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-28	CI
AB Science SA Summarizes Presentation on Masitinib in Amyotrophic Lateral Sclerosis at American Academy of Neurology 2023 Annual Meeting in Boston, USA	23-04-27	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights AB Science

Equities

AB

FR0010557264

Highlights

Filters